Searchable abstracts of presentations at key conferences in endocrinology

ea0065p223 | Metabolism and Obesity | SFEBES2019

Untreated pre-operative mental illness is associated with poorer bariatric surgery outcomes

Sultman David , Whitelaw Benjamin

Background: Approximately 20% of bariatric surgery candidates are excluded for reasons of mental health. All bariatric patients undergo a pre-operative assessment of suitability, including a mental health assessment. There are no NICE guidelines as to what level of mental illness is considered an exclusion; it is generally regarded that ‘unstable mental health’ is a contraindication to surgery. The main reason is concern regarding adherence to essential lifestyle cha...

ea0059p020 | Adrenal and steroids | SFEBES2018

Addison’s at high altitude – developing an evidence based patient information resource for Addison’s patients who travel to high altitude

Coskeran Patsy , Mustafa Omar , Whitelaw Benjamin

Patients with Addison’s or adrenal insufficiency require regular steroid replacement usually in the form of oral hydrocortisone. Standard advice is given on how to deal with intercurrent illness and special situations such as surgery. Organisations such as the Addison’s disease self-help group provide authoritative guidelines for patients. Several of our patients with adrenal insufficiency have asked how their steroid replacement treatment should be adjusted for expe...

ea0050p287 | Neuroendocrinology and Pituitary | SFEBES2017

Inpatient endocrinology referrals: does the RCP report ‘Referring Wisely’ describe who should be referred?

Whitelaw Benjamin , Davies Zoe , Davis Laura May , Xekouki Paraskevi

The Royal College of Physicians (RCP) published a report called Referring Wisely in June 2017. The report asked specialty physicians for a short list of conditions they felt would benefit from specialist input in the context of acute inpatient management (recommended referrals). It also asked for a list of conditions which need not be referred (avoid referrals).Methods: We retrospectively audited inpatient referrals from our electronic inpatient referral...

ea0050p287 | Neuroendocrinology and Pituitary | SFEBES2017

Inpatient endocrinology referrals: does the RCP report ‘Referring Wisely’ describe who should be referred?

Whitelaw Benjamin , Davies Zoe , Davis Laura May , Xekouki Paraskevi

The Royal College of Physicians (RCP) published a report called Referring Wisely in June 2017. The report asked specialty physicians for a short list of conditions they felt would benefit from specialist input in the context of acute inpatient management (recommended referrals). It also asked for a list of conditions which need not be referred (avoid referrals).Methods: We retrospectively audited inpatient referrals from our electronic inpatient referral...

ea0086p105 | Neuroendocrinology and Pituitary | SFEBES2022

Case Series: Primary / neo-adjuvant 131I-MIBG therapy as a safe and effect treatment in the management of pheochromocytoma / paraganglioma

Onyema Michael , Crane James , Reynolds Saira , Whitelaw Benjamin

Background: As per 2014 Endocrine Society guidelines, 131I-MIBG therapy is usually reserved for metastatic or unresectable disease in patients with pheochromocytoma / paraganglioma. In this series, we describe three patients effectively treated with primary 131I-MIBG therapy. The indications were primary neo-adjuvant therapy prior to surgery, or palliative.Case series: Case 1 – 18-year-old male with a 60 mm para-aortic paragang...

ea0044p33 | Adrenal and Steroids | SFEBES2016

What is the most appropriate cut-off for post-saline aldosterone in saline suppression test after adrenalectomy?

Ranasinghe Ruvini , Taylor David , Whitelaw Benjamin , Aylwin Simon , Vincent Royce

Introduction: Primary aldosteronism (PA) is the most common endocrine cause of hypertension affecting up-to 10% of hypertensives. Saline suppression, a confirmatory test for PA helps avoiding patients undergoing invasive lateralisation procedures due to a false positive aldosterone-to-renin ratio (ARR). The proposed cut-off to exclude PA is post-saline aldosterone suppression to <140 pmol/l. We reviewed our biochemical work-up in order to optimise laboratory assessment.</p...

ea0034p51 | Clinical biochemistry | SFEBES2014

Hyponatraemia prior to discharge from hospital after a general medical admission is associated with a significantly increased risk of readmission within 28 days

Solanki Pratik , Whitelaw Benjamin , Leong Christine , Miell John , Aylwin Simon

Hyponatraemia is associated with adverse outcomes including increased mortality and risk of falls. It is not previously known whether hyponatraemia, on discharge from hospital, is associated with an increased risk of readmission.We conducted a retrospective cohort study identifying all patients admitted to a UK teaching hospital as emergency general medical admissions over a 2-month period. We identified all readmissions within 28 days of discharge and c...

ea0034p66 | Clinical practice/governance and case reports | SFEBES2014

Severe hypercalcaemia requiring emergency haemodialysis due to postpartum hypophysitis and thyroiditis

Gao Jing Mia , Whitelaw Benjamin , Mustafa Omar , Cheeroth Salim

A 34-year-old African woman presented with a 4-month history of profound lethargy, weight loss and a 3-day history of vomiting, fever, confusion, and drowsiness. She had given birth to her third child 6 months previously. Her pregnancy and delivery were uncomplicated and she had breastfed for 5 months prior to discontinuing due to exhaustion.Investigations showed severe hypercalcaemia (4.94 mmol/l) and undetectable PTH. Hypercalcaemia was unresponsive to...

ea0082p16 | Poster Presentations | SFEEU2022

Just another pituitary lesion

Bodi Istavan , Albusaidi Ayisha , Shapey Jonathan , Whitelaw Benjamin , Iftikhar Sahar , Aylwin Simon

Case history: 37F presented with 4 years history of amenorrhea. In addition, she had fatigue, low mood and joint pains. She also had history of polyuria and nocturia. Investigations: Her investigations revealed FSH 2.4 IU/l, LH 1.1 IU/l, Oestradiol < 92 pmol/l, T4 <5 pmol/l, TSH 1.5 mIU/l, IGF-1 13.3 nmol/l (8.5- 30.07), Cortisol 65 nmol/l, Prolactin 68 mIU/l. She was started on Hydrocortisone and levothyroxine. Pituitary MRI revealed a 15 mm les...

ea0086p91 | Neuroendocrinology and Pituitary | SFEBES2022

Diabetes insipidus safety: Automated electronic records alert to identify patients with diabetes insipidus in hospital

Clave Llavall Anna , Aquino Maia , Teo James , Mustafa Omar G. , Whitelaw Benjamin C.

Background: Cranial diabetes insipidus (DI) is characterised by the inability to produce vasopressin leading to uncontrolled diuresis. Management includes administering synthetic vasopressin analogue desmopressin (DDAVP). Recently, there have been several national reports of DDAVP omission causing serious patient harm. This study aims to evaluate the feasibility of an automated alert system using Natural Language Processing (NLP) in electronic health records (EHR) to detect DI...